VEGFA and neoplasm: Fortunately, since the first studies involving VEGF-targeted therapy in humans [27, 28], advances in research and diagnosis of physiological and tumor angiogenesis, vascular anomalies, and cardiovascular disease have shed light on other molecular mechanisms important for angiogenesis that could pave the way for the discovery of novel or more efficient therapeutic targets.